Arturo Rodríguez Jacob, CEO at Infinite Clinical Research (ICR) and president of the national association of CROs (ACROM), explains what make Mexico the regional clinical research hub and showcases how ICR is developing clinical studies for allopathic, biotech, medtech, and herbal medicine companies.
Only 15 years ago, the Mexican clinical trials industry was barely existent. However, Mexico is now one of the strongest clinical research hubs in Latin America taking over Argentina’s position. As president of the national association of CROs (ACROM), what are the main drivers that triggered such a transition?
"I am proud to confirm that the Mexican CRO industry now fully complies with the highest international quality standards."
